BevCanna Enterprises



FluroTest Diagnostic Systems Featured in Grand View Research Report Exploring Growth of COVID-19 Saliva Screening Test Potential Market

Former US Assistant Health Secretary Dr. Joxel Garcia Joins FluroTest as Chief Medical Officer and Executive Team Member

FluroTech Announces Closing of Amalgamation

FluroTech Announces Warrant Incentive Program Results Adding Over $1M to Company Treasury

FluroTest and SNC-Lavalin Sign MoU to Bring Saliva Sample-Based SARS-CoV-2 Testing Solution System to Market in Canada and Beyond

FluroTest Provides Clinical Trial Update for High Volume COVID-19 Rapid Antigen Testing System

FluroTech Announces Extension to Early Warrant Exercise Incentive Program

FluroTest Prepares to Detect SARS-CoV-2 Variants of Concern with High-Throughput COVID-19 Testing Platform

FluroTest Diagnostics Systems and Total Testing Solutions Sign Pilot Program MOU to Bring First High-Volume SARS-CoV-2 Testing System to California

FluroTech Announces Early Warrant Exercise Incentive Program

Former US Assistant Secretary for Health, Admiral Joxel Garcia, MD, Joins Flurotest Advisory Board to Support COVID-19 Rapid Antigen Testing System for the Masses

FluroTech Grants Options to the Board of Directors

FluroTech and FluroTest Announce Definitive Amalgamation Agreement

FluroTech Partners With Toolbox Medical Innovations for Clinical Trial of Mass-Scale COVID-19 Testing Platform

Robotics Automation Pioneer Phillip Farrelly Joins Flurotech Scientific Advisory Board

FluroTech and Hudson Robotics Begin Pandemic Response Unit Pre-Production

FluroTech Adds Life Sciences Expert Dr. Timothy J. Holzer to Scientific Advisory Board

Brian Shield, Boston Red Sox VP of IT, Joins Flurotech Advisory Board

FluroTech Provides Executive Update on Program Advancements

FluroTech Retains Market-Making Services

FluroTech Expands nanoComposix Mandate; Initiating Covid-19 Test Performance Evaluation and Validation


Filings Format Description Filing Date File/Film Number